21

1

Logo

CRISPR STEM and THERAPEUTICS lTD

Company | Israel

Primary tabs

About your organization

Crispr Stem & Therapeutics (CST) Ltd is an Israel-based startup company that developing a patented Cardio-Protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure. Our vision is to offer a personalized cell therapy treatment, that will save lives and increase life expectancy following acute heart attack and chronic heart failure. Our protocol was tested in several proofs of concept experiments both in vitro and in vivo in animal models and had shown dramatically decreased damage to the heart. We are proud to say that CST Ltd received the recognition from the Israeli Authorities (Tnuffa) and from the European Commission with two Seals of Excellence. Our vision that our product will be used frequently so as stents in the emergency at hospitals. CST Ltd. is looking for investors to complete the pre-clinical phase and GMP protocol (kit). For further talk and information please contact Dalia El-Ani (Ph.D) Founder & CEO

Watch Dalia El-Ani lecturer about  CRISPR STEM and THERAPEUTICS LTD:

https://www.youtube.com/watch?v=SJf-HfFirk4&t=1s

Contact us:

E-mail: DaliaE@CrisprStemTherapeutics.com

Our website

http://www.CrisprStemTherapeutics.com/

Our LinkedIn:

https://www.linkedin.com/company/crispr-stem-therapeutics-ltd/posts/?feedView=all&viewAsMember=true

Dalia El-Ani LinkedIN:

https://www.linkedin.com/in/Dalia-El-Ani/

 

Network (0)

There are no organizations in the network.

Dataroom

You are not connected

A certain number of contents are currently hidden from you, and you do not have access to the linking functionalities.

Log in or register To access the complete range of contents and functionalities, simply subscribe. The subscription process is quick and free of charge.

Recent activity

You are not connected

A certain number of contents are currently hidden from you, and you do not have access to the linking functionalities.

Log in or register To access the complete range of contents and functionalities, simply subscribe. The subscription process is quick and free of charge.